Skip to main content

Table 1 Patient demographic, disease, and treatment characteristics

From: Indirect costs associated with out-of-country referral for proton therapy: a survey of adult and pediatric patients in Alberta, Canada

Characteristic All Patients (n = 17) Adult Patients (n = 8) Pediatric Patients (n = 9)
Median age at treatment, years (range) 14 (1–68) 47 (25–68) 9 (1–14)
Gender
 Female 13 (76%) 8 (100%) 5 (56%)
 Male 4 (24%) 0 (0%) 4 (44%)
Diagnosis
 Chordoma 1 (6%) 1 (13%) 0 (0%)
 Chondrosarcoma 6 (35%) 6 (75%) 0 (0%)
 Craniopharyngioma 3 (18%) 1 (13%) 0 (0%)
 Osteoblastoma 1 (6%) 0 (0%) 3 (33%)
 Medulloblastoma 2 (12%) 0 (0%) 2 (22%)
 Nongerminomatous germ cell tumor 2 (12%) 0 (0%) 2 (22%)
 Ependymoma 1 (6%) 0 (0%) 1 (11%)
 Rhabdomyosarcoma 1 (6%) 0 (0%) 1 (11%)
Referral location
 Jacksonville, FL 8 (47%) 0 (0%) 8 (89%)
 Boston, MA 5 (29%) 5 (63%) 0 (0%)
 Loma Linda, CA 3 (18%) 3 (38%) 0 (0%)
 Memphis, TN 1 (6%) 0 (0%) 1 (11%)
Treatment Year
 2009–2013 5 (29%) 4 (50%) 1 (11%)
 2014–2018 12 (71%) 4 (50%) 8 (89%)
Median number of fractions (range) 33 (20–40) 37 (35–40) 30 (20–33)
Median length of stay in US, days (range) 61 (44–81) 65 (52–81) 56 (44–62)
  1. Percentages in each category may not total 100% due to rounding